MSB 3.21% $1.13 mesoblast limited

Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes, page-154

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    going on 10 years now of lip-service.....

    NVS will one day "maybe" pay them for progress.

    its in annual report again on repeat....
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.